New criteria require evidence of cardiac dysfunction, hemodynamic abnormalities, and end-organ hypoperfusion, potentially improving the recognition of cardiogenic shock.
Cardiogenic shock care extends beyond rapid decision-making at the bedside, a new review asserts. Clearer understanding of shock’s diversity and how best to tackle its acute manifestations, as well as ...
More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...
A head-to-head comparison of inotropes in the setting of cardiogenic shock revealed no clear victor, with milrinone and dobutamine providing similar outcomes in the randomized DOREMI trial. A ...
The Company recently announced the positive topline results from the Phase 2b study with istaroxime in acute heart failure patients with early cardiogenic shock WARRINGTON, Pa., Oct. 09, 2024 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results